Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v3-EN
Language English English
Date Updated 2019-04-01 2019-02-20
Drug Identification Number 02229145 02229145
Brand name NORVIR NORVIR
Common or Proper name Norvir Oral Solution Norvir Oral Solution
Company Name ABBVIE CORPORATION ABBVIE CORPORATION
Ingredients RITONAVIR RITONAVIR
Strength(s) 80MG 80MG
Dosage form(s) SOLUTION SOLUTION
Route of administration ORAL ORAL
Packaging size 240mL 240mL
ATC code J05AE J05AE
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-03-31 2019-03-31
Actual discontinuation date 2019-03-31 2019-03-31
Remaining supply date 2019-03-31 2019-03-31
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments AbbVie routinely and carefully assesses our portfolio, including our existing and anticipated pipeline to determine what is best for our customers and our business. This decision is in line with Norvir’s phase in the product lifecycle. AbbVie routinely and carefully assesses our portfolio, including our existing and anticipated pipeline to determine what is best for our customers and our business. This decision is in line with Norvir’s phase in the product lifecycle.
Health Canada comments